These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32960547)

  • 21. Gas chromatographic-mass spectrometric quantitation of busulfan in human plasma for therapeutic drug monitoring: a new on-line derivatization procedure for the conversion of busulfan to 1,4-diiodobutane.
    Athanasiadou I; Angelis YS; Lyris E; Archontaki H; Georgakopoulos C; Valsami G
    J Pharm Biomed Anal; 2014 Mar; 90():207-14. PubMed ID: 24389463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of UHPLC-MS/MS methods for the quantification of colistin in plasma and dried plasma spots.
    Cangemi G; Barco S; Castagnola E; Tripodi G; Favata F; D'Avolio A
    J Pharm Biomed Anal; 2016 Sep; 129():551-557. PubMed ID: 27505127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children : validation of liquid chromatography tandem mass spectrometry method.
    Rauh M; Stachel D; Kuhlen M; Gröschl M; Holter W; Rascher W
    Clin Pharmacokinet; 2006; 45(3):305-16. PubMed ID: 16509762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring.
    Matar KM; Alshemmari SH; Refaat S; Anwar A
    Sci Rep; 2020 Jun; 10(1):8913. PubMed ID: 32488110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI-MS/MS: Application in clinical study.
    Namdev KK; Dwivedi J; Chilkoti DC; Sharma S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():362-369. PubMed ID: 29223050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous online SPE-HPLC-MS/MS quantification of gefitinib, osimertinib and icotinib in dried plasma spots: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
    Jia M; Wu Z; Shi W; Wang S; Huang X; Zhang M; Bao W; Bao A; Zhang P; Ding F; Xie G; Lou Y; Fan G
    J Pharm Biomed Anal; 2023 May; 228():115275. PubMed ID: 36871365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rapid and simple LC-MS/MS method for personalized busulfan dosing in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT).
    Xiao Y; Li X; Fu X
    Clin Chim Acta; 2018 Apr; 479():190-195. PubMed ID: 29341904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation.
    Ansari M; Théoret Y; Rezgui MA; Peters C; Mezziani S; Desjean C; Vachon MF; Champagne MA; Duval M; Krajinovic M; Bittencourt H;
    Ther Drug Monit; 2014 Feb; 36(1):93-9. PubMed ID: 24061446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Simple Liquid Chromatography Tandem Mass Spectrometry Method for Quantitation of Plasma Busulfan.
    Deng S; Kiscoan M; Frazee C; Abdel-Rahman S; Dalal J; Garg U
    Methods Mol Biol; 2016; 1383():79-87. PubMed ID: 26660176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients.
    Bhatnagar A; McKay MJ; Thaysen-Andersen M; Arasaratnam M; Crumbaker M; Gurney H; Molloy MP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121741. PubMed ID: 31421381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A UHPLC-MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots.
    Pigliasco F; Cafaro A; Simeoli R; Barco S; Magnasco A; Faraci M; Tripodi G; Goffredo BM; Cangemi G
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Simple and Accurate Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Busulfan in Plasma.
    Lee EJ; Park N; Lee SH; Lee W; Kim HS; Chun S; Min WK
    Ann Clin Lab Sci; 2019 Mar; 49(2):212-217. PubMed ID: 31028066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rapid HPLC-MS/MS method for determining busulfan in hemolytic samples from children with hematopoietic stem cell transplantation.
    Jinjie Y; Sun N; Zhang S; Feng X; Chen X; Zhao D; Zhao L
    Biomed Chromatogr; 2020 Sep; 34(9):e4898. PubMed ID: 32428257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.
    Gonzalez D; Melloni C; Poindexter BB; Yogev R; Atz AM; Sullivan JE; Mendley SR; Delmore P; Delinsky A; Zimmerman K; Lewandowski A; Harper B; Lewis KC; Benjamin DK; Cohen-Wolkowiez M;
    Bioanalysis; 2015; 7(9):1137-49. PubMed ID: 26039810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study.
    Bezinelli LM; Eduardo FP; de Carvalho DLC; Dos Santos Ferreira CE; de Almeida EV; Sanches LR; Esteves I; Campregher PV; Hamerschlak N; Corrêa L
    Bone Marrow Transplant; 2017 Oct; 52(10):1384-1389. PubMed ID: 28737776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of lithium in dried blood spots and dried plasma spots by graphite furnace atomic absorption spectrometry: Method development, validation and clinical application.
    Manfro ID; Tegner M; Krutzmann ME; Artmann ADC; Brandeburski MR; Peteffi GP; Linden R; Antunes MV
    Talanta; 2020 Aug; 216():120907. PubMed ID: 32456895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    dos Reis EO; Vianna-Jorge R; Suarez-Kurtz G; Lima EL; Azevedo Dde A
    Rapid Commun Mass Spectrom; 2005; 19(12):1666-74. PubMed ID: 15912469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma busulfan.
    French D; Sujishi KK; Long-Boyle JR; Ritchie JC
    Ther Drug Monit; 2014 Apr; 36(2):169-74. PubMed ID: 24625541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots.
    Baldelli S; Cattaneo D; Giodini L; Baietto L; Di Perri G; D'Avolio A; Clementi E
    Clin Chem Lab Med; 2015 Feb; 53(3):435-44. PubMed ID: 25153419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individualizing oral busulfan dose after using a test dose in patients undergoing hematopoietic stem cell transplantation: pharmacokinetic characterization.
    Effting C; de Moraes Arantes A; Queiroz Labre LV; Carneiro WJ; de Oliveira Neto JR; Bariani C; Rodrigues CR; Rodrigues AR; Cunha LC
    Ther Drug Monit; 2015 Feb; 37(1):66-70. PubMed ID: 25588069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.